Galectin Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $134k | 32k | 4.23 |
| 2025-06-30 | $354k | 168k | 2.11 |
| 2025-03-31 | $64k | 52k | 1.22 |
| 2024-12-31 | $67k | 52k | 1.29 |
| 2024-09-30 | $39k | 14k | 2.75 |
| 2024-06-30 | $30k | 13k | 2.26 |
| 2023-12-31 | $1.0k | 622 | 1.66 |
| 2022-12-31 | $6.3k | 5.6k | 1.13 |
| 2022-06-30 | $2.0k | 1.8k | 1.13 |
| 2021-09-30 | $8.0k | 2.0k | 4.02 |
| 2021-06-30 | $3.0k | 1.0k | 3.00 |
| 2021-03-31 | $14k | 6.5k | 2.20 |
| 2020-12-31 | $53k | 24k | 2.25 |
| 2020-09-30 | $8.0k | 3.0k | 2.67 |
| 2020-06-30 | $38k | 12k | 3.06 |
| 2020-03-31 | $49k | 25k | 1.96 |
| 2019-12-31 | $154k | 51k | 3.00 |
| 2019-09-30 | $123k | 33k | 3.67 |
| 2019-06-30 | $72k | 18k | 4.00 |
| 2019-03-31 | $34k | 6.7k | 5.06 |
| 2018-12-31 | $31k | 9.1k | 3.40 |
| 2018-09-30 | $12k | 2.0k | 6.14 |
| 2018-06-30 | $46k | 7.2k | 6.41 |
| 2018-03-31 | $32k | 6.1k | 5.28 |
| 2017-09-30 | $14k | 6.6k | 2.11 |
| 2017-06-30 | $6.0k | 2.4k | 2.49 |
| 2017-03-31 | $9.0k | 3.7k | 2.43 |
| 2016-12-31 | $1.0k | 841 | 1.19 |
| 2016-06-30 | $9.0k | 5.9k | 1.52 |
| 2016-03-31 | $0 | 90 | 0.00 |
| 2015-12-31 | $0 | 90 | 0.00 |
| 2015-09-30 | $7.2k | 3.0k | 2.44 |
| 2015-03-31 | $6.2k | 1.6k | 3.86 |